Basit öğe kaydını göster

dc.contributor.authorTufekcioglu, Zeynep
dc.contributor.authorEmre, Murat
dc.contributor.authorHanagasi, Haşmet Ayhan
dc.date.accessioned2021-03-05T21:50:28Z
dc.date.available2021-03-05T21:50:28Z
dc.identifier.citationHanagasi H. A. , Tufekcioglu Z., Emre M., "Dementia in Parkinson's disease", JOURNAL OF THE NEUROLOGICAL SCIENCES, cilt.374, ss.26-31, 2017
dc.identifier.issn0022-510X
dc.identifier.othervv_1032021
dc.identifier.otherav_dad19169-7d4a-46c3-bb4d-a41db973a5df
dc.identifier.urihttp://hdl.handle.net/20.500.12627/144227
dc.identifier.urihttps://doi.org/10.1016/j.jns.2017.01.012
dc.description.abstractDementia can occur in a substantial number of patients with Parkinson's disease with a point prevalence close to 30%. The cognitive profile is characterized by predominant deficits in executive, visuospatial functions, attention and memory. Behavioral symptoms are frequent such as apathy, visual hallucinations and delusions. The most prominent associated pathology is Lewy body-type and biochemical deficit is cholinergic. Placebo-controlled randomized trials with cholinesterase inhibitors demonstrated modest but significant benefits in cognition, behavioral symptoms and global functions. (C) 2017 Elsevier B.V. All rights reserved.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSinirbilim ve Davranış
dc.subjectNEUROSCIENCES
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleDementia in Parkinson's disease
dc.typeMakale
dc.relation.journalJOURNAL OF THE NEUROLOGICAL SCIENCES
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume374
dc.identifier.startpage26
dc.identifier.endpage31
dc.contributor.firstauthorID240817


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster